home / stock / lobe:cc / lobe:cc news

LOBE:CC News and Press, Lobe Sciences Ltd.

Stock Information
Company Name: Lobe Sciences Ltd.
Stock Symbol: LOBE:CC
Market: CNQC
Website: lobesciences.com
Menu
LOBE:CC LOBE:CC Quote LOBE:CC Short LOBE:CC News LOBE:CC Articles LOBE:CC Message Board
Get LOBE:CC Alerts

News, Short Squeeze, Breakout and More Instantly...
LOBE:CC - Lobe Sciences Announces Appointment of Mr. Mirza Rahimani, CPA, CA as Chief Financial Officer

VANCOUVER, BC / ACCESS Newswire / March 9, 2026 / Lobe Sciences Ltd. (Lobe) (CSE:LOBE)(OTCQB:LOBEF)(Frankfurt:LOBE) is a Canadian public biopharmaceutical company incorporated in British Columbia, with principal executive offices in Florida. The Company identifies and advances therapeutic prog...
LOBE:CC - Lobe Sciences Ltd. Announces Presence in Miami During the Jefferies and Leerink Healthcare Conferences

VANCOUVER, BRITISH COLUMBIA / ACCESS Newswire / March 5, 2026 / Lobe Sciences Ltd. (Lobe) (CSE:LOBE)(OTCQB:LOBEF)(Frankfurt:LOBE) is a Canadian public biopharmaceutical company incorporated in British Columbia, with principal executive offices in Florida. The Company identifies and advances th...

LOBE:CC - Lobe Sciences Reports First Quarter 2026 Results and Highlights

VANCOUVER, BC / ACCESS Newswire / February 3, 2026 / Lobe Sciences Ltd. (CSE:LOBE)(OTCQB:LOBEF)(Frankfurt:LOBE.F) ("Lobe" or the "Company"), a biopharmaceutical company advancing programs in diseases with unmet medical needs, today reported unaudited financial results for the first quarter of ...

LOBE:CC - Lobe Sciences Advances Governance and Capital Markets Expertise with Appointment of Mr. Nick Karakochuk to the Board of Directors

VANCOUVER, BRITISH COLUMBIA / ACCESS Newswire / January 13, 2026 / Lobe Sciences Ltd. (" Lobe Sciences " or the " Company ") (CSE: LOBE)( OTCQB: LOBEF)( FWB: LOBE.F ), a clinical-stage biopharmaceutical company focused on advancing therapies for diseases with significant unmet medical needs, t...
LOBE:CC - Lobe Sciences Reports FY2025 with a Stronger Balance Sheet and Sharpened Strategy

Balance Sheet and Sharpened Strategy VANCOUVER, BRITISH COLUMBIA / ACCESS Newswire / January 8, 2026 / Lobe Sciences Ltd. (CSE: LOBE)( OTCQB: LOBEF)( Frankfurt: LOBE.F ) (" Lobe " or the " Company "), a biopharmaceutical company advancing programs in diseases with unmet medical needs, t...

LOBE:CC - Lobe Sciences Reports Fiscal 2025 Results and Highlights Strategic Transformation Following Leadership Transition

VANCOUVER, BRITISH COLUMBIA / ACCESS Newswire / January 6, 2026 / Lobe Sciences Ltd. (CSE: LOBE )(OTCQB: LOBEF )(FWB: LOBE.F ) (" Lobe " or the " Company "), a biopharmaceutical company advancing programs in diseases with unmet medical needs, today reported audited financial results for the ...

LOBE:CC - CSE Bulletin: MOC Eligibility Update

Toronto, Ontario--(Newsfile Corp. - November 27, 2025) - The following CSE-Listed symbol will become MOC Eligible as detailed below. Effective date: December 2, 2025   The full list of MOC-Eligible symbols is available at https://thecse.com/trading/trading-resources/#market-on-clos...
LOBE:CC - Lobe Sciences Completes Debt Settlement to Improve Balance Sheet

VANCOUVER, BC / ACCESS Newswire / October 23, 2025 / Lobe Sciences Ltd. ("Lobe" or the "Company") (CSE:LOBE)(OTCQB:LOBEF)(FWB:LOBE.F), operates as a pharmaceutical platform that develops novel therapies through a scalable model of shared services, global teams, and outsourced infrastructure. T...

LOBE:CC - Lobe Sciences Improves Balance Sheet

VANCOUVER, BRITISH COLUMBIA / ACCESS Newswire / October 9, 2025 / Lobe Sciences Ltd. ("Lobe" or the "Company") (CSE:LOBE)(OTCQB:LOBEF)(FWB:LOBE.F), operates as a pharmaceutical platform that develops novel therapies through a scalable model of shared services, global teams, and outsourced infr...

LOBE:CC - Lobe Sciences Ltd. to Attend the ArcStone-Kingswood Growth Summit 2025 in Toronto

Vancouver, British Columbia--(Newsfile Corp. - September 15, 2025) - Lobe Sciences Ltd . (CSE: LOBE) (OTCQB: LOBEF) (FSE: LOBE.F) ("Lobe Sciences" or the "Company") a clinical stage biopharmaceutical company focused on developing products to treat diseases with significant unmet medica...
Next 10